6562 Organometallics, Vol. 27, No. 24, 2008
Wallenhorst et al.
3
4
600 MHz, 298 K): δ(1H) 8.04 (dd, J ) 7.8 Hz, J ) 1.0 Hz, 1H,
123.5 (C-3py), 122.9 (C-5py), 105.8 (-CHd), 77.2 (dCH2), 65.1
(dNCH2-), 35.8 (dNCH2CH2-), 27.9 (-CHA(CH3)2), 27.7 (-CH-
3-Hpy), 7.77 (t, 3J ) 7.8 Hz, 1H, 4-Hpy), 7.69 (dd, 3J ) 7.8 Hz, 4J
B(CH3)2), 25.7 (-CHA(CH3 CH3 )), 25.5 (-CHB(CH3 CH3 )), 25.3
3
4
A
B
A
B
) 1.0 Hz, 1H, 5-Hpy), 7.46 (dd, J ) 7.8 Hz, J ) 1.4 Hz, 1H,
(-CHA(CH3ACH3 )), 25.1 (-CHB(CH3ACH3 )), 20.1 (-CH3aryl),
17.3 (-CH3alk).
B
B
3-Haryl), 7.30 (t, 3J ) 7.8 Hz, 1H, 4-Haryl), 7.24 (br, 3H, Php), 7.12
3
4
(br, 6H, Pho), 7.02 (br, 6H, Phm), 6.83 (d, J ) 7.8 Hz, J ) 1.4
Hz, 1H, 5-Haryl), 6.06 (dddd, 3J ) 17.6 Hz, 3J ) 10.2 Hz, 3J ) 9.4
Hz, 3J ) 3.5 Hz, 1H, -CHd), 4.93 (dm, 3J ) 10.2 Hz, 1H, dCH2E),
X-ray crystal structure analysis of 7b: formula C25H33Cl2N3Ru,
Mr ) 547.51, black crystal, 0.30 × 0.20 × 0.10 mm, a ) 15.651(1)
Å, b ) 10.898(1) Å, c ) 30.092(1) Å, ꢀ ) 91.90(1)°, V ) 5129.8(6)
Å3, Fcalcd ) 1.418 g cm-3, µ ) 0.836 mm-1, empirical absorption
correction (0.788 e T e 0.921), Z ) 8, monoclinic, space group
P21/c (No. 14), λ ) 0.710 73 Å, T ) 198 K, ω and ꢁ scans, 18 264
reflections collected ((h, (k, (l), (sin θ)/λ ) 0.62 Å-1, 10 141
independent (Rint ) 0.053) and 6661 observed reflections (I g
2σ(I)), 599 refined parameters, R1 ) 0.056, wR2 ) 0.141,
maximum (minimum) residual electron density 1.61 (-0.64) e Å-3
close to the metal centers, two almost identical molecules, one with
disorder in the chain (C26-C27-C28) refined with split positions,
hydrogen atoms calculated and refined as riding atoms.
4.82 (dm, 3J ) 17.6 Hz, 1H, dCH2 ), 4.72 (sept, 3J ) 6.8 Hz, 1H,
Z
-CHB(CH3)2), 4.31 (dm, J ) 13.4 Hz, 1H, dNCH2 -), 2.54 (s,
2
A
3H, -CH3aryl), 2.51 (dd, 2J ) 13.4 Hz, 3J ) 9.4 Hz, 1H,
B
3
dNCH2 -), 2.34 (s, 3H, -CH3alk), 2.09 (sept, J ) 6.8 Hz, 1H,
-CHA(CH3)2), 1.48 (d, 3J ) 6.8 Hz, 3H, -CHB(CH3ACH3 )), 0.93
B
(d, J ) 6.8 Hz, 3H, -CHB(CH3ACH3 )), 0.82 (d, J ) 6.8 Hz,
3
B
3
3H, -CHA(CH3ACH3 )), -0.60 (d, 3J ) 6.8 Hz, 3H, -CHA-
B
(CH3ACH3 )). 13C{1H} NMR (d2-dichloromethane, 150 MHz, 298
B
K): δ(13C) 175.1 (CdNaryl), 173.0 (d, ∑3JP,C + JP,C ) 1.3 Hz,
4
CdNalk), n.o. (Phi), 164.7 (C-6py), 164.5 (d, ∑3JP,C + JP,C ) 1.3
4
Hz, C-2py), 147.4 (C-1aryl), 145.3 (C-2aryl), 140.1 (C-6aryl), 134.9
(-CHd), 129.9 (Php), 128.9 (C-4py), n.o. (Pho), 127.5 (Phm), 127.4
(C-4aryl), 126.3 (C-3py), 125.1 (C-3aryl), 124.7 (C-5aryl), 124.4 (C-
5py), 115.8 (dCH2), 56.7 (dNCH2-), 28.4 (-CHB(CH3)2), 27.9
Preparation of Complex 7c. A solution of the bis(2,6-imino-
ethyl)pyridine ligand 5c (1.39 g, 3.56 mmol, 2 equiv) and [RuCl2(p-
cymene)]2 (1.10 g, 1.78 mmol) in 60 mL of ethanol was refluxed
under argon for 16 h. Subsequently the volume of the solvent was
reduced in vacuo until a purple solid began to form. The
precipitation was completed by addition of 60 mL of pentane and
the solid was collected by filtration, washed with pentane until the
solvent was colorless, and dried in vacuo to give the air-stable
product (69%, 1.49 g, 2.47 mmol). Slow evaporation from a
saturated dichloromethane solution gave single crystals of 7c for
the X-ray crystal structure analysis. Mp (DSC): 288 °C dec. MS-
ESI (MeOH/CHCl3, ES+): m/z 526.1 ([M - Cl])+, 490.2 ([M - 2
Cl])+. Anal. Calcd for C26H35Cl2N3Ru · 0.5CH2Cl2 (604.03): C,
(-CHA(CH3)2), 26.2 (-CHB(CH3ACH3 )), 24.8 (-CHA(CH3
-
B
A
CH3 )), 23.9 (-CHB(CH3ACH3 )), 22.8 (-CHA(CH3ACH3 )), 22.0
(-CH3aryl), 16.8 (-CH3alk). 31P{1H} NMR (d2-dichloromethane, 121
MHz, 298 K): δ(31P) 38.1 (s).
B
B
B
X-ray crystal structure analysis of 6a: formula C42H46-
Cl2N3PRu · CH2Cl2, Mr ) 880.68, red crystal, 0.35 × 0.35 × 0.03
mm, a ) 9.688(1)Å, b ) 11.853(1) Å, c ) 36.224(1) Å, ꢀ )
93.24(1)°, V ) 4153.0(6) Å3, Fcalcd ) 1.409 g cm-3, µ ) 0.707
mm-1, empirical absorption correction (0.790 e T e 0.979), Z )
4, monoclinic, space group P21/n (No. 14), λ ) 0.710 73 Å, T )
198 K, ω and ꢁ scans, 42 153 reflections collected ((h, (k, (l),
(sin θ)/λ ) 0.67 Å-1, 10 013 independent (Rint ) 0.051) and 8176
observed reflections (I g 2σ(I)), 491 refined parameters, R1 )
0.046, wR2 ) 0.135, maximum (minimum) residual electron density
2.30 (-0.82) e Å-3 close to the disordered solvent molecule,
hydrogen atoms calculated and refined as riding atoms.
1
52.69; H, 6.01; N, 6.96. Found: C, 53.38; H, 6.36; N, 6.96. H
NMR (d2-dichloromethane, 600 MHz, 298 K): δ(1H) 7.98 (m, 2H,
3-Hpy, 5-Hpy), 7.89 (m, 1H, 4 Hpy), 7.32 (m, 1H, 4-Haryl), 7.29 (m,
1H, 5-Haryl), 7.25 (m, 1H, 3-Haryl), 5.65 (m, 1H, -CHd), 4.34 (d,
3J ) 13.8 Hz, 1H, dCH2 ), 4.05 (d, J ) 8.9 Hz, 1H, dCH2 ),
Z
3
E
4.02 (dm, 2J ) 13.2 Hz, 1H, dNCH2A-), 3.97 (dm, 2J ) 13.2 Hz,
1H, dNCH2 -), 3.23 (sept, 3J ) 6.6 Hz, 1H, -CHA(CH3)2), 2.96
B
Preparation of Complex 7b. A solution of the bis(2,6-
iminoethyl)pyridine ligand 5b (613 mg, 1.63 mmol, 2 equiv) and
[RuCl2(p-cymene)]2 (503 mg, 0.82 mmol) in 60 mL of ethanol was
refluxed under argon for 16 h. Subsequently the volume of the
solvent was reduced in vacuo until a purple solid began to form.
The precipitation was completed by addition of pentane, and the
solid was collected by filtration, washed with pentane until the
solvent was colorless, and dried in vacuo to give the air-stable
product (61%, 549 mg, 1.00 mmol). Slow evaporation from a
saturated dichloromethane solution gave single crystals of 7b for
the X-ray crystal structure analysis. Mp (DSC): >350 °C. MS-ESI
(MeOH/CHCl3, ES+): m/z 512.3 ([M - Cl])+. Anal. Calcd for
C25H33Cl2N3Ru (547.53): C, 54.84; H, 6.08; N, 7.67. Found: C,
54.81; H, 5.91; N, 7.44. 1H NMR (d2-dichloromethane, 600 MHz,
298 K): δ(1H) 7.92 (dd, 3J ) 7.8 Hz, 4J ) 0.8 Hz, 1H, 3-Hpy), 7.86
(m, 1H, dNCH2CH2CH2A-), 2.94 (sept, 3J ) 6.6 Hz, 1H,
-CHB(CH3)2), 2.93 (s, 3H, -CH3alk), 2.67 (s, 3H, -CH3aryl), 2.26
B
(m, 1H, dNCH2CH2CH2 -), 2.07 (m, 1H, dNCH2CH2A-), 1.95
(m, 1H, dNCH2CH2 -), 1.11 (d, 3J ) 6.6 Hz, 3H, -CHA-
B
(CH3ACH3 )), 0.98 (d, 3J ) 6.6 Hz, 6H, -CHA(CH3ACH3 ),
B
B
-CHB(CH3 CH3 )), 0.93 (d, 3J ) 6.6 Hz, 3H, -CHB(CH3 CH3 )).
13C{1H} NMR (d2-dichloromethane, 150 MHz, 298 K): δ(13C) 174.3
(CdNaryl), 170.0 (CdNalk), 158.0 (C-6py), 157.1 (C-2py), 146.1 (C-
1aryl), 141.3 (C-6aryl), 141.3 (C-2aryl), 132.5 (C-4py), 127.3 (C-4aryl),
125.0 (C-5aryl), 124.6 (C-3aryl), 124.2, 123.5 (C-5py o. C-3py), 94.4
(-CHd), 78.1 (dCH2), 52.3 (dNCH2-), 27.8 (-CHA(CH3)2), 27.7
(-CHB(CH3)2), 26.9 (dNCH2CH2CH2-), 25.9 (dNCH2CH2-),
A
B
A
B
25.6 (-CHA(CH3ACH3 )), 25.6, 25.4 (-CHA(CH3ACH3 ),
B
B
-CHB(CH3ACH3 )), 25.3 (-CHB(CH3ACH3 )), 20.8 (-CH3aryl),
17.2 (-CH3alk).
B
B
(t, J ) 7.8 Hz, 1H, 4-Hpy), 7.80 (dd, J ) 7.8 Hz, J ) 0.8 Hz,
3
3
4
1H, 5-Hpy), 7.29 (m, 1H, 5-Haryl), 7.29 (m, 1H, 4-Haryl), 7.24 (m,
X-ray crystal structure analysis of 7c: formula C26H35-
Cl2N3Ru · 0.5CH2Cl2, Mr ) 604.00, black crystal, 0.60 × 0.40 ×
0.30 mm, a ) 25.836(1) Å, b ) 10.897(1) Å, c ) 19.487(1) Å, ꢀ
) 96.40(1)°, V ) 5452.1(6) Å3, Fcalcd ) 1.472 g cm-3, µ ) 0.889
mm-1, empirical absorption correction (0.618 e T e 0.776), Z )
8, monoclinic, space group C2/c (No. 15), λ ) 0.710 73 Å, T )
198 K, ω and ꢁ scans, 17 326 reflections collected ((h, (k, (l),
(sin θ)/λ ) 0.67 Å-1, 6506 independent (Rint ) 0.036) and 5809
observed reflections (I g 2σ(I)), 309 refined parameters, R1 )
0.054, wR2 ) 0.155, maximum (minimum) residual electron density
1.70 (-2.23) e Å-3 close to the disordered solvent molecule,
hydrogen atoms calculated and refined as riding atoms.
1H, 3-Haryl), 6.17 (m, 1H, -CHd), 4.54 (d, J ) 14.8 Hz, 1H,
3
Z
2
3
dCH2 ), 4.47 (dd, J ) 15.3 Hz, J ) 6.0 Hz, 1H, dNCH2A-),
4.35 (m, 1H, dNCH2 -), 4.10 (d, 3J ) 9.3 Hz, 1H, dCH2 ), 3.41
B
E
(sept, J ) 6.8 Hz, 1H, -CHA(CH3)2), 3.03 (sept, J ) 6.8 Hz,
3
3
1H, -CHB(CH3)2), 2.99 (m, 1H, dNCH2CH2A-), 2.83 (s, 3H,
2
3
3
-CH3alk), 2.61 (s, 3H, -CH3aryl), 2.53 (dq, J ) 12.3 Hz, J ) J
) 6.4 Hz, 1H, dNCH2CH2 -), 1.14 (d, 3J ) 6.8 Hz, 3H,
B
-CHA(CH3 CH3 )), 1.01 (d, 3J ) 6.8 Hz, 3H, -CHA(CH3 CH3 )),
A
B
A
B
0.96 (d, J ) 6.8 Hz, 3H, -CHB(CH3ACH3 )), 0.94 (d, J ) 6.8
3
B
3
Hz, 3H, -CHB(CH3ACH3 )). 13C{1H} NMR (d2-dichloromethane,
B
150 MHz, 298 K): δ(13C) 174.3 (CdNaryl), 167.9 (CdNalk), 160.0
(C-6py), 157.5 (C-2py), 146.1 (C-1aryl), 141.1 (C-6aryl), 140.9 (C-
2aryl), 133.4 (C-4py), 127.0 (C-4aryl), 124.9 (C-5aryl), 124.6 (C-3aryl),
Preparation of Complex 7d. A solution of the bis(2,6-
iminoethyl)pyridine ligand 5d (500 mg, 1.24 mmol, 2 equiv) and